The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Dual versus single immune checkpoint blockade for patients with metastatic colorectal cancer harboring microsatellite instability: The Saint-Antoine immunoMSI score.
 
Léa Jehanno
No Relationships to Disclose
 
Romain Cohen
Honoraria - AstraZeneca/Daiichi Sankyo; AstraZeneca/Daiichi Sankyo; Bristol-Myers Squibb; Bristol-Myers Squibb; MSD Oncology; Mylan; Pierre Fabre; SERVIER; SERVIER; SERVIER
Consulting or Advisory Role - Bristol-Myers Squibb; Enterome; Exeliom Biosciences
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; MSD Oncology; Mylan; SERVIER; SERVIER
 
Camille Loisel
No Relationships to Disclose
 
Thomas Samaille
Consulting or Advisory Role - Merck Serono
Travel, Accommodations, Expenses - Merck Serono
 
Baptiste Cervantes
Travel, Accommodations, Expenses - Merck Serono
 
Raphael Colle
No Relationships to Disclose
 
Julie Henriques
No Relationships to Disclose
 
Dewi Vernerey
No Relationships to Disclose
 
Thierry Andre
Honoraria - Bristol-Myers Squibb; Merck; Merck Serono; Sanofi; Seagen; SERVIER
Consulting or Advisory Role - Abbvie; Aptitude Health; Bristol-Myers Squibb; Gilead Sciences; GlaxoSmithKline; MSD Oncology; Nimbus Therapeutics; Nordic Bioscience; Pfizer; Seagen; SERVIER; Takeda
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MSD Oncology; Takeda
Other Relationship - Inspirna
(OPTIONAL) Uncompensated Relationships - Adjuvant Colon Cancer End Points (ACCENT) Collaborative Group; ARCAD Foundation; ARCAD Foundation